SPPI - Spectrum Pharmaceuticals' CRL: There Is Very Little Clarity August, 12 2021 08:00 AM Spectrum Pharmaceuticals Inc. SPPI received a surprise CRL for rolontis. This could be resolved before the year is out, but there is no real clarity. The company does have enough cash to last it for a year or more. For further details see: Spectrum Pharmaceuticals' CRL: There Is Very Little Clarity